Pharmaceutical Executive
Pharmaceutical Executive: October 2026
Volume: 46
Issue: 8
Pharmaceutical Executive: September 2026
Volume: 46
Issue: 7
Pharmaceutical Executive: August 2026
Volume: 46
Issue: 6
Pharmaceutical Executive: June 2026
Volume: 46
Issue: 5
Pharmaceutical Executive: May 2026
Volume: 46
Issue: 4
Pharmaceutical Executive: April 2026
Volume: 46
Issue: 3
Pharmaceutical Executive: March 2026
Volume: 46
Issue: 2
Pharmaceutical Executive: February 2026
Volume: 46
Issue: 1
Pharmaceutical Executive: December 2025
Volume: 45
Issue: 9
Pharmaceutical Executive: October 2025
Volume: 45
Issue: 8
Pharmaceutical Executive: September 2025
Volume: 45
Issue: 7
Pharmaceutical Executive: August 2025
Volume: 45
Issue: 6
Pharmaceutical Executive: June 2025
Volume: 45
Issue: 5
Pharmaceutical Executive: May 2025
Volume: 45
Issue: 4
Pharmaceutical Executive: April 2025
Volume: 45
Issue: 3
Pharmaceutical Executive: March 2025
Volume: 45
Issue: 2
Pharmaceutical Executive: February 2025
Volume: 45
Issue: 1
Pharmaceutical Executive: December 2024
Volume: 44
Issue: 12
Pharmaceutical Executive: November 2024
Volume: 44
Issue: 11
Pharmaceutical Executive: October 2024
Volume: 44
Issue: 10
Pharmaceutical Executive: September 2024
Volume: 44
Issue: 9
Pharmaceutical Executive: July/August 2024
Volume: 44
Issue: 7/8
Pharmaceutical Executive: June 2024
Volume: 44
Issue: 6
Pharmaceutical Executive: May 2024
Volume: 44
Issue: 5
Pharmaceutical Executive: April 2024
Volume: 44
Issue: 4
Pharmaceutical Executive: March 2024
Volume: 44
Issue: 3
Pharmaceutical Executive: February 2024
Volume: 44
Issue: 1
Pharmaceutical Executive: December 2023
Volume: 43
Issue: 12
Pharmaceutical Executive: November 2023
Volume: 43
Issue: 11
Pharmaceutical Executive: October 2023
Volume: 43
Issue: 10
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Enspryng (Satralizumab) for Thyroid Eye Disease
2
AstraZeneca Taps insitro AI for MASH in Deal Worth Up to $1.5 Billion
3
EMA Panel Backs Lilly’s Foundayo for Obesity and Type 2 Diabetes in Europe
4
The Bubble You Don’t Know You’re In: A Three-Part Series on The Medical Benefit Bubble
5